支气管动脉栓塞术联合药物治疗支气管扩张所致咯血的临床研究

Clinical Study of Bronchial Arterial Embolism Combined with Medication in the Treatment of Hemoptysis Caused by Bronchiectasis

目的研究支气管动脉栓塞术联合药物治疗支气管扩张所致咯血的临床效果。方法选择2017年6月至2019年6月本院收治的60例支气管扩张所致咯血患者,随机分为两组各30例。对照组行酚妥拉明联合垂体后叶注射液治疗,观察组在对照组基础上实施支气管动脉栓塞术治疗。比较两组的临床疗效、咯血停止时间及不良反应。结果观察组的总有效率为93.33%,显著高于对照组的73.33%(P<0.05)。观察组的咯血停止时间显著短于对照组(P<0.05)。两组的不良反应发生率无统计学差异(P>0.05)。结论支气管动脉栓塞术联合药物治疗支气管扩张所致咯血具有显著的效果,可缩短咯血停止时间,安全性高。

Objective To study the clinical effect of bronchial arterial embolism combined with medication in the treatment of hemoptysis caused by bronchiectasis.Methods A total of 60 patients with hemoptysis caused by bronchiectasis admitted to our hospital from June 2017 to June 2019 were selected and randomly divided into two groups equally. The control group was treated with phentolamine combined with posterior pituitary injection, and the observation group was treated with bronchial arterial embolism on the basis of the control group. The clinical efficacy, stopping time of hemoptysis and adverse reactions were compared between two groups.Results The total effective rate of observation group was 93.33%, significantly higher than 73.33% of control group(P<0.05). The stopping time of hemoptysis of observation group was significantly shorter than that of control group(P<0.05). No significant difference was found in the incidence of adverse reactions between two groups(P>0.05).Conclusions Bronchial arterial embolism combined with medication in the treatment of hemoptysis caused by bronchiectasis has significant effect and high safety, and can shorten the stopping time of hemoptysis.